In contrast, in our study, the combination of the Nrf2*C/C genotype and the SOD2*C allele amplified the risk of PC development when compared to carriers of both the Nrf2*A allele and the SOD2*T/T genotype. The gene discussed is NFE2L2; the disease is pachyonychia congenita.